Cargando…

Breaking the Therapeutic Ceiling: Dual Biologic or Small Molecule Therapy for Refractory Inflammatory Bowel Disease

Detalles Bibliográficos
Autor principal:	Ahmed, Waseem
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Invited Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802154/ https://www.ncbi.nlm.nih.gov/pubmed/36777549 http://dx.doi.org/10.1093/crocol/otac005

Ejemplares similares

Effectiveness of Dual Biologic or Small Molecule Therapy for Achieving Endoscopic Remission in Refractory Inflammatory Bowel Disease
por: Abdullah, Israa, et al.
Publicado: (2022)

Breaking the Crystal Ceiling
por: Gebel Berg, Erika
Publicado: (2015)

Women in Surgical Fields; Time to break the Glass Ceiling
por: Malik, Tayyaba Gul
Publicado: (2021)

Therapeutic drug monitoring in inflammatory bowel disease
por: Kopylov, Uri, et al.
Publicado: (2014)

Advances in the development of new biologics in inflammatory bowel disease
por: Ungar, Bella, et al.
Publicado: (2016)

Use of biologics and chemotherapy in patients with inflammatory bowel diseases and cancer
por: Jauregui-Amezaga, Aranzazu, et al.
Publicado: (2016)

Women in Translational Medicine: Tools to Break the Glass Ceiling
por: Bots, Sophie H., et al.
Publicado: (2018)

Breaking Green Ceilings: podcasting for environmental and social change
por: Mulki, Sapna, et al.
Publicado: (2021)

The role of small-bowel endoscopy in inflammatory bowel disease: an updated review on the state-of-the-art in 2021
por: Skamnelos, Alexandros, et al.
Publicado: (2021)

Poor Clinician Adherence to Inflammatory Bowel Disease Guidelines: How Do We Remedy the Situation?
por: Hart, Lara, et al.
Publicado: (2022)

Language and medicine: Breaking the barriers in gynaecological cancer
por: Brennan, Donal J.
Publicado: (2021)

Optimizing Medication Access and Use in Inflammatory Bowel Disease: The Roles and Impact of Clinical Pharmacists and Pharmacy Technicians
por: Bhat, Shubha
Publicado: (2023)

Intestinal Ultrasound Is the Ideal Patient-Centric, Point-of-Care Tool for Clinical Decision Making in the Inflammatory Bowel Disease Practice
por: Dolinger, Michael Todd, et al.
Publicado: (2023)

Monitoring and Safety of Azathioprine Therapy in Inflammatory Bowel Disease
por: Kim, Mi Jin, et al.
Publicado: (2013)

New biologics and small molecules in inflammatory bowel disease: an update
por: Sabino, João, et al.
Publicado: (2019)

Rheumatological manifestations in inflammatory bowel disease
por: Voulgari, Paraskevi V.
Publicado: (2011)

The history of genetics in inflammatory bowel disease
por: Ek, Weronica E., et al.
Publicado: (2014)

The use of ultrasound in inflammatory bowel disease
por: Kucharzik, Torsten, et al.
Publicado: (2017)

Small bowel enteroscopy in Crohn’s disease
por: Moreels, Tom G.
Publicado: (2012)

miRNA Molecules—Late Breaking Treatment for Inflammatory Bowel Diseases?
por: Aggeletopoulou, Ioanna, et al.
Publicado: (2023)

Endocrine and metabolic manifestations in inflammatory bowel disease
por: Tigas, Stelios, et al.
Publicado: (2012)

Familial and ethnic risk in inflammatory bowel disease
por: Santos, Maria Pia Costa, et al.
Publicado: (2018)

Role of bile acids in inflammatory bowel disease
por: Tiratterra, Elisa, et al.
Publicado: (2018)

Bile Acid Signaling in Inflammatory Bowel Diseases
por: Fiorucci, Stefano, et al.
Publicado: (2020)

Psychological factors associated with inflammatory bowel disease
por: Eugenicos, M P, et al.
Publicado: (2021)

Precision medicine in inflammatory bowel disease: Individualizing the use of biologics and small molecule therapies
por: Cheah, Eric, et al.
Publicado: (2023)

Small bowel imaging in Crohn’s disease patients
por: Gauci, James, et al.
Publicado: (2018)

An overview of lipid abnormalities in patients with inflammatory bowel disease
por: Agouridis, Aris P., et al.
Publicado: (2011)

Clostridium difficile infection in patients with inflammatory bowel disease
por: Saidel-Odes, Lisa, et al.
Publicado: (2011)

Manipulating bone disease in inflammatory bowel disease patients
por: Miheller, Pal, et al.
Publicado: (2013)

Electrolyte and acid-base disorders in inflammatory bowel disease
por: Barkas, Fotis, et al.
Publicado: (2013)

Management of cutaneous disorders related to inflammatory bowel disease
por: Pellicer, Zaira, et al.
Publicado: (2012)

Epidemiology of intrafamilial inflammatory bowel disease throughout Europe
por: Arias-Loste, Maria Teresa, et al.
Publicado: (2012)

Diagnosis and treatment of anemia in patients with inflammatory bowel disease
por: Mücke, Victoria, et al.
Publicado: (2017)

Treatment of Pyoderma Gangrenosum in Pediatric Inflammatory Bowel Disease
por: Vaidy, Katherine, et al.
Publicado: (2020)

Whitewash for Ceilings
Publicado: (1890)

Adjuvant chemotherapy in locally advanced cervical cancer: the ceiling remains unbroken
por: Gupta, Sudeep
Publicado: (2019)

Positioning of old and new biologicals and small molecules in the treatment of inflammatory bowel diseases
por: Reinglas, Jason, et al.
Publicado: (2018)

Role of the combination of biologics and/or small molecules in the treatment of patients with inflammatory bowel disease
por: Balderramo, Domingo
Publicado: (2022)

Breath Testing and Small Bowel Organisms in Clinical Practice
por: Baker, Susan S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c2gvenpj123shnhn3je3jmn308